Health Canada approves use of Dolphin Vagal Nerve Stimulator
The device is intended to treat symptoms like shortness of breath, cough, fatigue, joint and muscle pain, headaches,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 May 22
The device is intended to treat symptoms like shortness of breath, cough, fatigue, joint and muscle pain, headaches,…
13 Apr 22
The Passio pump drainage system is designed for the drainage of recurrent and symptomatic pleural effusions and malignant…
15 Mar 22
This acquisition will help Sandoz to build on its current portfolio of respiratory medicines and boost patient access…
09 Mar 22
RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the…
07 Mar 22
XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms and CT scans…
16 Feb 22
Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals
15 Feb 22
Lungpacer has designed its AeroPace system to stimulate the nerves that activate the diaphragm to strengthen independent breathing
09 Feb 22
HeroTracker Sense is a next generation metered-dose inhaler (MDI) add-on connected device, which will help to address patient…
09 Feb 22
RheOx is a new system that endoscopically delivers non-thermal pulsed electric field (PEF) energy to the lung airways…
07 Feb 22
This decision is based on the receipt of reports that some bellavista 1000 and 1000e ventilators have unintentionally…